VisionQuest Biomedical ^Company

VisionQuest Biomedical is a medical device company using artificial intelligence to end preventable blindness. EyeStar, the company's first software application, is used to diagnose diabetic retinopathy in patients' eyes, and Aspire detects malarial retinopathy. The new i-RxTherm is VisionQuest's first technological effort to detect early-stage diabetic disease in areas other than the eyes.

VisionQuest's mission is to create and deploy image-based technologies that will improve access to health care for millions of people in the United States and around the world, particularly in the areas of diabetes and eye care.